An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 774-776

  Higuchi, Katsuhiko ^a   Tanabe, Satoshi ^a   Koizumi, Wasaburo ^a   Nakayama, Norisuke ^a   Sasaki, Tohru ^a   Nagaba, Shizuka ^a   Saigenji, Katsunori ^a   Katada, Natsuya ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

CYP2C19; Extensive metabolizer; Lansoprazole; Recurrent ulcer

Indexed keywords

LANSOPRAZOLE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MEGADOSE; DUODENUM ULCER; ENZYME ACTIVITY; GASTROINTESTINAL ENDOSCOPY; GENOTYPE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; PATIENT COMPLIANCE; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; ARYL HYDROCARBON HYDROXYLASES; DUODENAL ULCER; GASTRIC ACIDITY DETERMINATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; OMEPRAZOLE; RECURRENCE;

EID: 2342471321     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 2 antagonists in acute upper gastrointestinal hemorrhage. N Engl J Med 1985; 313:660-666.
2. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, Sodi JS: A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336:1054-1058.
3. Stabile B, Passaro E: Recurrent peptic ulcer. Gastroenterology 1976; 70:124-135.
4. Pearce RE, Rodrigues AD, Goldstein JA, Parkinson A: Identification of human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther 1996; 277:805-816.
5. Sohn DR, Kwon JT, Kim HK, Ishizaki T: Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4′-hydroxylation phenotype status. Clin Pharmacol Ther 1997; 61:674-582.
6. Katsuki H, Nakamura C, Arimori K, Fujiyama S, Nakano M: Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subject. Eur J Clin Pharmacol 1997; 52:391-396.
7. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, Taufer M, Wurzer H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328:308-312.
8. Graham DY, Lew GM, Klein PD, Evans DG, Evans DG, Saeed ZA, Malaty HM: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study. Ann Intern Med 1992; 116:705-708.
9. Thirlby R: Postoperative recurrent ulcer. Gastroenterol Clin North Am 1994; 23:295-311.
10. Kubota T, Chiba K, Ishizaki T: Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population. Clin Pharmacol Ther 1996; 60:661-666.
11. Furuta T, Shirai N, Xiao F, Ohashi K, Ishizaki T: Effect of high-dose lansoprazole on intragastric pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19. Clin Pharmacol Ther 2001; 70:484-492.
12. Adachi K, Katsube T, Kawamura A, Takashima T, Yuki M, Amano K, Ishihara S, Fukuda R, Watanabe M, Kinoshita Y: CYP2C19 genotype status and intragastric pH during dosing with lanaoprazole or rabeprazole. Aliment Pharmacol Ther 2000; 14:1259-1266.